Year archive

Aequus Pharmaceuticals Inc. — 2025 filings

All 14 regulatory filings released by Aequus Pharmaceuticals Inc. (AQS) in 2025, sourced directly from the official regulator.

14 Filings

2025 Period

2025 filings (14)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-11-29	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-11-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-08-28	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-08-28	English
Interim MD&A - English.pdf Management Reports	2025-08-28	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H2 2025	2025-08-28	English
Statement of executive compensation (form 51-102F6V) - English.pdf Remuneration Information	2025-06-25	English
Material change report - English.pdf Regulatory Filings	2025-05-30	English
Material contracts - Credit agreements.pdf M&A Activity	2025-05-30	English
News release - English.pdf Earnings Release Q1 2025	2025-05-22	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-05-22	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-05-22	English
Interim MD&A - English.pdf Management Reports	2025-05-22	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-05-22	English